RecruitingNot ApplicableNCT05386277

A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter

A Post Market Clinical Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter on Patients Undergoing Surgical Treatment for the Removal of Arterial Emboli and/or Thrombi

Sponsor

LeMaitre Vascular

Enrollment

112 participants

Start Date

Jan 11, 2022

Study Type

INTERVENTIONAL

Conditions

Arterial Thromboembolism

Summary

A post market clinical study to confirm the performance and safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter on patients undergoing surgical treatment for the removal of arterial emboli and/or thrombi

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called TufTex Single Lumen Embolectomy Catheter for people with arterial thromboembolism. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETufTex Single Lumen Embolectomy Catheter

The SLC Embolectomy Catheter is indicated for the removal of arterial emboli and thrombi

Locations(3)

Ziekenhuis Oost-Limburg

Genk, Belgium

Andrej Udelnow

Brandenburg, Germany

Giorgio Prouse

Lugano, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05386277

Related Trials

Aspiration Thrombectomy Using the Symphony or Prodigy System

NCT073504992 locations

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

NCT069506975 locations